TNFAIP3基因多态和血小板缺血的风险:伊朗人口的横截面研究
Sorour Alizadeh Saadooni1, Zeinab Eftekhar1, Mohammad Ali Jalali Far1
1Thalassemia & Hemoglobinopathy Research Center, Health Research Institute Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
Health science reports
|January 6, 2026
概括
TNFAIP3基因的遗传变异与血小板缺血风险有关. rs10499194的多态性显示出与风险增加的显著关联,特别是在非免疫性血小板缺血病例中.
科学领域:
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 血小板减少,以低血小板计数为特征,增加出血风险.
- 遗传因素,包括单核酸多态 (SNPs),有助于血栓细胞衰竭的发病.
- 作为炎症的负调节者,TNFAIP3基因与自身免疫性疾病有关.
研究的目的:
- 调查伊朗人群中TNFAIP3基因多态 (rs10499194和rs2230926) 与血小板缺血之间的关联.
- 为了确定TNFAIP3SNP的特定基因型是否与患血小板缺血的风险增加相关.
主要方法:
- 与156名参与者进行的横截面研究 (40名非免疫性血小板缩,38名自身免疫性血小板缩,78名健康对照).
- 通过使用Tetra-primer放大阻抗突变系统PCR对TNFAIP3rs10499194和rs2230926多态的基因定型.
- 患者组和健康对照组之间的基因型和等位基因频率的比较.
主要成果:
- 在rs10499194多态性显示显著的关联与增加的血小板缺血风险 (CT基因型:OR=2.5,p=0.02;TT基因型:OR=1.8,p=0.04).
- 在所有参与者之间没有观察到rs2230926多态的显著变化.
- 与健康对照组相比,rs10499194的CT和TT基因型在血小板缺血患者中更频繁.
结论:
- TNFAIP3 rs10499194多态性显著与血小板缺血有关,特别是非免疫类型,这表明存在遗传倾向.
- 在rs2230926中缺乏变异可能表明特定种群的遗传同质性.
- 建议进行更大规模的研究来验证这些发现,并探索TNFAIP3多形态在血小板缺血的临床含义.
更多相关视频
相关概念视频
Translation
155.2K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.2K
Translation
17.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.5K
Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196


